Enlivex ENLV
NASDAQ ENLV
$1.47 -0.03 (-2.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

Enlivex (ENLV) Sales of Property, Plant and Equipment (2017 - 2025)

Enlivex (ENLV) Sales of Property, Plant and Equipment (2017 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.85 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 698,426.11
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Enlivex 4.51 Mn -1.25 Mn - 1.37 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.37 Mn
Dec 31, 2025 1.37 Mn
Mar 31, 2025 1,000.00
Mar 31, 2025 1,000.00
Dec 31, 2024 1.93 Mn
Dec 31, 2024 1.93 Mn
Sep 30, 2024 6,000.00
Sep 30, 2024 6,000.00
Mar 31, 2024 171,000.00
Mar 31, 2024 171,000.00
Dec 31, 2023 51,000.00
Dec 31, 2023 51,000.00
Dec 31, 2019 -71,000.00
Dec 31, 2019 -71,000.00
Dec 31, 2017 -1,000.00
Dec 31, 2017 -1,000.00